E
XTL Biopharmaceuticals Ltd. XTLB
$0.8038 -$0.0557-6.48%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Weiss Ratings XTLB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Rating E
Reward Index Very Weak
Risk Index Very Weak
Risk Grade E+
Reward Grade E+
Rating Factors XTLB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index --
Growth Index Very Weak
Efficiency Index Very Weak
Solvency Index Good
Total Return Index Very Weak
Volatility Index Weak
Beta / Standard Deviation XTLB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Beta 0.96
Price History XTLB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return -5.44%
30-Day Total Return -11.41%
60-Day Total Return -23.46%
90-Day Total Return -17.95%
Year to Date Total Return -17.76%
1-Year Total Return -42.58%
2-Year Total Return -66.23%
3-Year Total Return -75.04%
5-Year Total Return -65.05%
52-Week High % Change -44.19%
52-Week Low % Change 14.60%
Price XTLB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $1.54
52-Week Low Price $0.75
52-Week Low Price (Date) Jul 25, 2023
52-Week High Price (Date) Apr 17, 2023
Valuation XTLB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Market Cap $5.09M
Enterprise Value 2.78M
Price/Earnings (TTM) --
Earnings Per Share (TTM) 0.00
Earnings Per Share Growth 212.50%
Price/Earnings To Growth --
Price/Sales (TTM) --
Price/Book (Q) 117.74
Enterprise Value/Revenue (TTM) --
Price $0.80
Enterprise Value/EBITDA (TTM) -3.16
Enterprise Value/EBIT -3.16
Market Cap Category Nano Cap
Dividends and Shares XTLB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 544.906M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info XTLB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 972 3 611 6600
Address --
Website www.xtlbio.com
Country Israel
Year Founded 1993
Profitability XTLB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) --
Profit Margin --
Management Effectiveness XTLB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets -10.18%
Return on Equity --
Income Statement XTLB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) --
Total Revenue (TTM) --
Revenue Per Share --
Gross Profit (TTM) --
EBITDA (TTM) -$879.20K
EBIT (TTM) -$880.00K
Net Income (TTM) -$1.35M
Net Income Avl. to Common (TTM) -$1.35M
Total Revenue Growth (Q YOY) --
Earnings Growth (Q YOY) -135.70%
EPS Diluted (TTM) $0.00
EPS Diluted Growth (Q YOY) -158.33%
Balance Sheet XTLB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) $3.72M
Cash Per Share (Q) $0.01
Total Current Assets (Q) $3.81M
Total Preferred Equity (Q) --
Total Equity (Q) $4.00M
Current Ratio (Q) 20.353
Book Value Per Share (Q) $0.01
Total Assets (Q) $4.19M
Total Current Liabilities (Q) $187.00K
Total Debt (Q) $0.00
Total Liabilities (Q) $187.00K
Total Common Equity (Q) $4.00M
Cash Flow XTLB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) --
Cash from Financing (TTM) --
Net Change in Cash (TTM) --
Levered Free Cash Flow (TTM) --
Cash from Operations (TTM) --
Weiss Ratings